Page 218 - An Evidence Review of Active Surveillance in Men With Localized Prostate Cancer

Appendix Table C1.2. Trends in prostate cancer incidence rates (per 100,000 unless otherwise stated) (continued)
Author Database Groups 1980-84 1985-89 1990-94 1995-99 2000-04 2005- Statistical Notes
Year 10 analysis
PMID
76
Danley LAC/USC Localized 1.8 (1.4, P<0.001 Additional
1995 CSP Regional 2.3) (for difference information
8580296 Metastatic 11.3 between is
Unstaged (9.9, stage groups presented
Percent annual 12.6) for the linear in Figure 2
change of the 1.6 (0.7, trend over yr, of the
stage-specific 2.4) 1976-88) paper.
incidence rate 3.2 (2.1,
[Non-Hispanic 4.4)
White] (1976-
88)
LAC/USC Localized -1.0 P<0.001 Additional
CSP Regional (−2.3, (for difference information
Metastatic 0.4) between is
Unstaged 8.3 (4.3, stage groups presented
Percent annual 12.5) for the linear in Figure 2
change of the 0.4 trend over yr, of the
stage-specific (−1.9, 1976-88) paper.
incidence rate 2.6)
[Hispanic White] 1.7
(−1.8,
5.3)
(1976-
88)
LAC/USC Localized -0.5 P<0.001 Additional
CSP Regional (−1.6, (for difference information
Metastatic 0.6) between is
Unstaged 7.7 (4.5, stage groups presented
Percent annual 10.9) for the linear in Figure 2
change of the 1.4 trend over yr, of the
stage-specific (−0.4, 1976-88) paper.
incidence rate 3.1)
[Black] 1.2
(−1.3,
3.8)
(1976-
88)

C-27